Tongli Pharmaceuticals (USA), Inc. Stock

Tongli Pharmaceuticals (USA), Inc. through its wholly owned subsidiary, Harbin Tianmu Pharmaceuticals Co., Ltd. (HTP), is a pharmaceutical company engaged in the production, manufacturing and distribution of both prescription and non-prescription over-the-counter (OTC) medicines in China. The company has the following types of productions: tablets, capsules, granules, oral liquid, etc, more than 10 types. The annual capacity of the company includes 300 million tablets, 250 million capsules, 10 million bags of granules and 36 million pipes of oral liquid. The Company's products are Calcium Gluconate Oral Solution, Blood Circulation Peomotion Oral Solution, Antihyperlipidemics, Gynecologic Leucorrhea Stopping Tablet, Panax and Radix Polygoni Capsule, among others.